Caitlin Raymond – D is for Decoy: Apparent Rh-Specificity in Warm Autoantibodies
Caitlin Raymond, Assistant Professor of Pathology and Transfusion Medicine at the University of Wisconsin-Madison, posted on LinkedIn:
”D is for Decoy: When “anti-D” isn’t what it seems
An O-positive patient’s plasma looked like it contained anti-D – until the autocontrol came back positive and the eluate was a panagglutinin.
That combination changes everything.
When plasma reactivity appears Rh-specific but the eluate reacts with everything, you’re not dealing with alloimmunization or passive antibody. You’re seeing an autoantibody with apparent Rh specificity – one of those beautifully deceptive patterns that teaches you to read between the agglutination lines.
In this new Blood, Bytes, and Beyond post, I walk through:
– The testing logic behind ruling out partial D and passive anti-D
– Why Rh-complex autoantibodies often mimic anti-D, anti-e, or anti-C
– How to document these cases clearly so no one chases a phantom alloantibody later
For anyone who’s ever stared at a positive autocontrol and thought “wait a second…,” this one’s for you.”
Read the full post here.
Stay informed with Hemostasis Today.
-
Aug 11, 2026, 07:50When Access to Care Changes Everything – WFH
-
Aug 11, 2026, 07:35Kuldeep Singh Bhadauria: Building the Future of Hemophilia Care in India
-
Aug 11, 2026, 07:28Archil Jaliashvili: When Every Minute Matters Time Becomes a Therapy
-
Aug 11, 2026, 07:05Mavis Agnes Kisakye: Building Sustainable Transition Pathways in Hemophilia Care
-
Aug 11, 2026, 06:48Rishdha Roshad: What Happens to the Brain During Cardiopulmonary Bypass?
-
Aug 11, 2026, 05:53Isaac Okello: Strengthening Sickle Cell Advocacy in Uganda
-
Aug 11, 2026, 05:38Rami Unterman: A Simple New Biomarker for Fibrotic ILDs
-
Aug 11, 2026, 04:10Haroun Gajraj: CLaCS vs Sclerotherapy – What Does the Evidence Show
-
Aug 11, 2026, 02:54Tareq Abadl: The Ultimate Guide to Clinically Significant Antibodies